HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Modarress, K. J. Articles by Simons Jr., S. S. Search for Related Content PubMed PubMed Citation Articles by Modarress, K. J. Articles by Simons Jr., S. S. Social Bookmarking                      What's this?

Volume 272, Number 38, Issue of September 19, 1997 pp. 23986-23994
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Steroid-induced Conformational Changes at Ends of the Hormone-binding Domain in the Rat Glucocorticoid Receptor Are Independent of Agonist Versus Antagonist Activity

(Received for publication, May 30, 1997, and in revised form, July 7, 1997)

From the Steroid Hormones Section, NIDDK/Laboratory of Molecular and Cellular Biology, National Institutes of Health, Bethesda, Maryland 20892

The underlying molecular mechanism for the expression of agonist versus antagonist activity for a given receptor-steroid complex is still not known. One attractive hypothesis, based on data from progesterone receptors, is that agonist versus antagonist binding induces unique conformations at the C terminus of receptors, which can be detected by the different fragments produced by partial proteolysis. We now report that the determinants of glucocorticoid receptor (GR)-antagonist complex activity are more complex. Steroid binding did cause a conformational change in the GR that was detected by partial trypsin digestion, as described previously (Simons, S. S., Jr., Sistare, F. D., and Chakraborti, P. K. (1989) J. Biol. Chem. 264, 14493-14497). However, there was no uniformity in the digestion patterns of unactivated or activated receptors bound by a series of six structurally different antagonists including the affinity labeling antiglucocorticoid dexamethasone 21-mesylate. A total of four resistant bands were observed on SDS-polyacrylamide gels in the range of 30-27 kDa. Using a series of point mutations and epitope-specific antibodies, it was determined that the 30-kDa species represented the entire C-terminal sequence of amino acids 518-795, whereas the other bands arose from additional N-terminal and/or C-terminal cleavages. Bioassays with GRs containing various point and deletion mutations failed to reveal any C-terminal alterations that could convert antagonists into biologically active agonists. Thus, the presence or absence of C-terminal amino acids of the GR did not uniquely determine either the appearance of smaller trypsin-resistant fragments or the nature of the biological response of receptor-bound antisteroids. When compared with the current model of the ligand-binding domain, which is based on the x-ray structures of the comparable region of thyroid and retinoic acid receptors, the present results suggest that sequences outside of the model structure are relevant for the binding and biological activity of GRs.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. J Kojetin, T. P Burris, E. V Jensen, and S. A Khan Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor Endocr. Relat. Cancer, December 1, 2008; 15(4): 851 - 870. [Abstract] [Full Text] [PDF]

				L. Fang, D. Ricketson, L. Getubig, and B. Darimont Unliganded and hormone-bound glucocorticoid receptors interact with distinct hydrophobic sites in the Hsp90 C-terminal domain PNAS, December 5, 2006; 103(49): 18487 - 18492. [Abstract] [Full Text] [PDF]

				N. Yoshikawa, K. Yamamoto, N. Shimizu, S. Yamada, C. Morimoto, and H. Tanaka The Distinct Agonistic Properties of the Phenylpyrazolosteroid Cortivazol Reveal Interdomain Communication within the Glucocorticoid Receptor Mol. Endocrinol., May 1, 2005; 19(5): 1110 - 1124. [Abstract] [Full Text] [PDF]

				S. S. Billecke, D. I. Draganov, Y. Morishima, P. J. M. Murphy, A. Y. Dunbar, W. B. Pratt, and Y. Osawa The Role of hsp90 in Heme-dependent Activation of Apo-neuronal Nitric-oxide Synthase J. Biol. Chem., July 16, 2004; 279(29): 30252 - 30258. [Abstract] [Full Text] [PDF]

				C. L. Smith and B. W. O'Malley Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators Endocr. Rev., February 1, 2004; 25(1): 45 - 71. [Abstract] [Full Text] [PDF]

				P. J. M. Murphy, Y. Morishima, H. Chen, M. D. Galigniana, J. F. Mansfield, S. S. Simons Jr., and W. B. Pratt Visualization and Mechanism of Assembly of a Glucocorticoid Receptor{middle dot}Hsp70 Complex That Is Primed for Subsequent Hsp90-dependent Opening of the Steroid Binding Cleft J. Biol. Chem., September 12, 2003; 278(37): 34764 - 34773. [Abstract] [Full Text] [PDF]

				W. B. Pratt and D. O. Toft Regulation of Signaling Protein Function and Trafficking by the hsp90/hsp70-Based Chaperone Machinery Experimental Biology and Medicine, February 1, 2003; 228(2): 111 - 133. [Abstract] [Full Text] [PDF]

				E. C. Henry and T. A. Gasiewicz Agonist but Not Antagonist Ligands Induce Conformational Change in the Mouse Aryl Hydrocarbon Receptor as Detected by Partial Proteolysis Mol. Pharmacol., February 1, 2003; 63(2): 392 - 400. [Abstract] [Full Text] [PDF]

				J. N. Miner, C. Tyree, J. Hu, E. Berger, K. Marschke, M. Nakane, M. J. Coghlan, D. Clemm, B. Lane, and J. Rosen A Nonsteroidal Glucocorticoid Receptor Antagonist Mol. Endocrinol., January 1, 2003; 17(1): 117 - 127. [Abstract] [Full Text] [PDF]

				S. Kaul, P. J. M. Murphy, J. Chen, L. Brown, W. B. Pratt, and S. S. Simons Jr. Mutations at Positions 547-553 of Rat Glucocorticoid Receptors Reveal That hsp90 Binding Requires the Presence, but Not Defined Composition, of a Seven-amino Acid Sequence at the Amino Terminus of the Ligand Binding Domain J. Biol. Chem., September 20, 2002; 277(39): 36223 - 36232. [Abstract] [Full Text] [PDF]

				P. J. Hauk, E. Goleva, I. Strickland, A. Vottero, G. P. Chrousos, K. O. Kisich, and D. Y. M. Leung Increased Glucocorticoid Receptor {beta} Expression Converts Mouse Hybridoma Cells to a Corticosteroid-Insensitive Phenotype Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 361 - 367. [Abstract] [Full Text] [PDF]

				I. Strickland, K. Kisich, P. J. Hauk, A. Vottero, G. P. Chrousos, D. J. Klemm, and D. Y.M. Leung High Constitutive Glucocorticoid Receptor {beta} in Human Neutrophils Enables Them to Reduce Their Spontaneous Rate of Cell Death in Response to Corticosteroids J. Exp. Med., February 26, 2001; 193(5): 585 - 594. [Abstract] [Full Text] [PDF]

				N. Farman and M.-E. Rafestin-Oblin Multiple aspects of mineralocorticoid selectivity Am J Physiol Renal Physiol, February 1, 2001; 280(2): F181 - F192. [Abstract] [Full Text] [PDF]

				Y. Morishima, K. C. Kanelakis, A. M. Silverstein, K. D. Dittmar, L. Estrada, and W. B. Pratt The Hsp Organizer Protein Hop Enhances the Rate of but Is Not Essential for Glucocorticoid Receptor Folding by the Multiprotein Hsp90-based Chaperone System J. Biol. Chem., March 15, 2000; 275(10): 6894 - 6900. [Abstract] [Full Text] [PDF]

				G. Giannoukos, A. M. Silverstein, W. B. Pratt, and S. S. Simons Jr. The Seven Amino Acids (547-553) of Rat Glucocorticoid Receptor Required for Steroid and Hsp90 Binding Contain a Functionally Independent LXXLL Motif That Is Critical for Steroid Binding J. Biol. Chem., December 17, 1999; 274(51): 36527 - 36536. [Abstract] [Full Text] [PDF]

				D. Szapary, Y. Huang, and S. S. Simons Jr. Opposing Effects of Corepressor and Coactivators in Determining the Dose-Response Curve of Agonists, and Residual Agonist Activity of Antagonists, for Glucocorticoid Receptor-Regulated Gene Expression Mol. Endocrinol., December 1, 1999; 13(12): 2108 - 2121. [Abstract] [Full Text]

				H. K. Tirupati, L. C. Shaw, and A. S. Lewin An RNA Binding Motif in the Cbp2 Protein Required for Protein-stimulated RNA Catalysis J. Biol. Chem., October 22, 1999; 274(43): 30393 - 30401. [Abstract] [Full Text] [PDF]

				N. Bhowmick, P. Narayan, and D. Puett Identification of Ionizable Amino Acid Residues on the Extracellular Domain of the Lutropin Receptor Involved in Ligand Binding Endocrinology, October 1, 1999; 140(10): 4558 - 4563. [Abstract] [Full Text]

				H. Poukka, P. Aarnisalo, U. Karvonen, J. J. Palvimo, and O. A. Janne Ubc9 Interacts with the Androgen Receptor and Activates Receptor-dependent Transcription J. Biol. Chem., July 2, 1999; 274(27): 19441 - 19446. [Abstract] [Full Text] [PDF]

				S. Roux, B. Terouanne, B. Couette, M.-E. Rafestin-Oblin, and J.-C. Nicolas Conformational Change in the Human Glucocorticoid Receptor Induced by Ligand Binding Is Altered by Mutation of Isoleucine 747 by a Threonine J. Biol. Chem., April 9, 1999; 274(15): 10059 - 10065. [Abstract] [Full Text] [PDF]

				A. T. Bender, A. M. Silverstein, D. R. Demady, K. C. Kanelakis, S. Noguchi, W. B. Pratt, and Y. Osawa Neuronal Nitric-oxide Synthase Is Regulated by the hsp90-based Chaperone System in Vivo J. Biol. Chem., January 15, 1999; 274(3): 1472 - 1478. [Abstract] [Full Text] [PDF]